High-dose versus standard-dose intermittent meropenem in critically ill patients: An observational cohort study.

In our cohort, 30-day mortality showed the same direction of effect as the 90-day endpoint but did not reach statistical significance, potentially due to the lower number of early deaths and consequently reduced statistical power to detect absolute risk differences, despite a relative difference exceeding 10%.

also in 111,027 other papers